Cas no 2172310-43-7 (2-(3-{(tert-butoxy)carbonylamino}bicyclo3.2.1octan-3-yl)acetic acid)
2-(3-{(tert-butoxy)carbonylamino}bicyclo3.2.1octan-3-yl)acetic acid Chemical and Physical Properties
Names and Identifiers
-
- 2-(3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl)acetic acid
- EN300-1283942
- 2172310-43-7
- 2-(3-{(tert-butoxy)carbonylamino}bicyclo3.2.1octan-3-yl)acetic acid
-
- Inchi: 1S/C15H25NO4/c1-14(2,3)20-13(19)16-15(9-12(17)18)7-10-4-5-11(6-10)8-15/h10-11H,4-9H2,1-3H3,(H,16,19)(H,17,18)
- InChI Key: CBDPFHTYQGBEHY-UHFFFAOYSA-N
- SMILES: O(C(C)(C)C)C(NC1(CC(=O)O)CC2CCC(C1)C2)=O
Computed Properties
- Exact Mass: 283.17835828g/mol
- Monoisotopic Mass: 283.17835828g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 20
- Rotatable Bond Count: 5
- Complexity: 387
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 2
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.3
- Topological Polar Surface Area: 75.6?2
2-(3-{(tert-butoxy)carbonylamino}bicyclo3.2.1octan-3-yl)acetic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-1286059-1.0g |
2-[(1R,5S)-3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl]acetic acid |
2172310-43-7 | 1g |
$0.0 | 2023-06-07 | ||
| Enamine | EN300-1283942-1.0g |
2-(3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl)acetic acid |
2172310-43-7 | 1g |
$0.0 | 2023-06-07 | ||
| Enamine | EN300-1286059-50mg |
2-[(1R,5S)-3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl]acetic acid |
2172310-43-7 | 50mg |
$707.0 | 2023-10-01 | ||
| Enamine | EN300-1286059-100mg |
2-[(1R,5S)-3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl]acetic acid |
2172310-43-7 | 100mg |
$741.0 | 2023-10-01 | ||
| Enamine | EN300-1286059-250mg |
2-[(1R,5S)-3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl]acetic acid |
2172310-43-7 | 250mg |
$774.0 | 2023-10-01 | ||
| Enamine | EN300-1286059-500mg |
2-[(1R,5S)-3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl]acetic acid |
2172310-43-7 | 500mg |
$809.0 | 2023-10-01 | ||
| Enamine | EN300-1286059-1000mg |
2-[(1R,5S)-3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl]acetic acid |
2172310-43-7 | 1000mg |
$842.0 | 2023-10-01 | ||
| Enamine | EN300-1286059-2500mg |
2-[(1R,5S)-3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl]acetic acid |
2172310-43-7 | 2500mg |
$1650.0 | 2023-10-01 | ||
| Enamine | EN300-1286059-5000mg |
2-[(1R,5S)-3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl]acetic acid |
2172310-43-7 | 5000mg |
$2443.0 | 2023-10-01 | ||
| Enamine | EN300-1286059-10000mg |
2-[(1R,5S)-3-{[(tert-butoxy)carbonyl]amino}bicyclo[3.2.1]octan-3-yl]acetic acid |
2172310-43-7 | 10000mg |
$3622.0 | 2023-10-01 |
2-(3-{(tert-butoxy)carbonylamino}bicyclo3.2.1octan-3-yl)acetic acid Related Literature
-
Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
-
Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
-
Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
Additional information on 2-(3-{(tert-butoxy)carbonylamino}bicyclo3.2.1octan-3-yl)acetic acid
Comprehensive Overview of 2-(3-{(tert-butoxy)carbonylamino}bicyclo[3.2.1]octan-3-yl)acetic acid (CAS No. 2172310-43-7)
2-(3-{(tert-butoxy)carbonylamino}bicyclo[3.2.1]octan-3-yl)acetic acid (CAS No. 2172310-43-7) is a specialized bicyclic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique bicyclo[3.2.1]octane scaffold and tert-butoxycarbonyl (Boc) protecting group, is widely utilized in the synthesis of complex molecules, particularly in drug discovery and development. Its structural features make it a valuable intermediate for constructing peptidomimetics and other bioactive molecules.
The growing interest in 2-(3-{(tert-butoxy)carbonylamino}bicyclo[3.2.1]octan-3-yl)acetic acid is driven by its potential applications in targeting G-protein-coupled receptors (GPCRs) and enzyme inhibitors, which are hot topics in current biomedical research. Researchers are particularly intrigued by its ability to modulate protein-protein interactions, a key focus area in the development of next-generation therapeutics. The compound's carboxylic acid functionality further enhances its versatility, allowing for easy derivatization and conjugation with other molecular entities.
In the context of green chemistry and sustainable synthesis, CAS No. 2172310-43-7 has also been explored as a building block for environmentally friendly processes. With the increasing demand for biocompatible materials and low-toxicity intermediates, this compound aligns well with modern trends in chemical innovation. Its stability under various conditions makes it suitable for large-scale production, addressing the needs of industrial applications.
Another area where 2-(3-{(tert-butoxy)carbonylamino}bicyclo[3.2.1]octan-3-yl)acetic acid shows promise is in the field of neuroscience. The bicyclic structure mimics natural neuroactive compounds, making it a candidate for studying neurodegenerative diseases such as Alzheimer's and Parkinson's. This connection to brain health and cognitive function has sparked interest among researchers and healthcare professionals alike, as these conditions remain a global health priority.
From a synthetic perspective, the Boc-protected amine group in this compound offers excellent selectivity and compatibility with a wide range of reaction conditions. This feature is particularly valuable in multistep synthesis, where protecting group strategies are critical. The compound's robustness and reliability have made it a staple in academic and industrial laboratories, contributing to its widespread adoption.
In summary, 2-(3-{(tert-butoxy)carbonylamino}bicyclo[3.2.1]octan-3-yl)acetic acid (CAS No. 2172310-43-7) is a multifaceted compound with broad applicability in drug discovery, neuroscience, and sustainable chemistry. Its unique structural attributes and functional groups position it as a key player in advancing scientific and medical breakthroughs. As research continues to evolve, this compound is expected to play an even greater role in addressing some of the most pressing challenges in modern science.
2172310-43-7 (2-(3-{(tert-butoxy)carbonylamino}bicyclo3.2.1octan-3-yl)acetic acid) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)